Cargando…
Current status of the adjuvant therapy in uterine sarcoma: A literature review
Uterine sarcomas (US) are rare mesenchymal tumours accounting approximately for 3%–7% of all uterine cancers. Histologically, US are classified into mesenchymal tumours or mixed epithelial and mesenchymal tumours. The group of mesenchymal tumours includes uterine leiomyosarcoma (uLMS, 65% of cases),...
Autores principales: | Rizzo, Alessandro, Pantaleo, Maria Abbondanza, Saponara, Maristella, Nannini, Margherita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692269/ https://www.ncbi.nlm.nih.gov/pubmed/31417921 http://dx.doi.org/10.12998/wjcc.v7.i14.1753 |
Ejemplares similares
-
Genetic aberrations and molecular biology of cardiac
sarcoma
por: Urbini, Milena, et al.
Publicado: (2020) -
(18)F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature
por: Saponara, Maristella, et al.
Publicado: (2018) -
Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib
por: Pantaleo, Maria Abbondanza, et al.
Publicado: (2012) -
Impact of Chemotherapy in the Adjuvant Setting of Early Stage Uterine Leiomyosarcoma: A Systematic Review and Updated Meta-Analysis
por: Rizzo, Alessandro, et al.
Publicado: (2020) -
Radiomics and Artificial Intelligence in Uterine Sarcomas: A Systematic Review
por: Ravegnini, Gloria, et al.
Publicado: (2021)